Skip to main content

BIODESIX INC (BDSX) Stock Forecast 2025 - AI Price Prediction & Analysis


BIODESIX INC (BDSX) AI Stock Price Forecast & Investment Analysis

BIODESIX INC Stock Price Chart and Technical Analysis

Loading BIODESIX INC interactive price chart and technical analysis...

BIODESIX INC (BDSX) - Comprehensive Stock Analysis & Investment Research

Deep dive into BIODESIX INC's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about BIODESIX INC, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For BIODESIX INC: BIODESIX INC operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

BIODESIX INC (Stock Symbol: BDSX) is a leading company in the Industrial Applications and Services sector , specifically operating within the Services-Medical Laboratories industry.

The organization employs approximately 252 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing BIODESIX INC's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For BIODESIX INC: With $76M in annual revenue and -66.8% net margin, the company demonstrates developing profitability.

Annual Revenue: $76 million generating a -66.8% net profit margin .

Market Capitalization: $987 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -234.3% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for BIODESIX INC stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For BIODESIX INC: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for BIODESIX INC stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: BIODESIX INC's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For BIODESIX INC: Market positioning analysis based on available financial and operational metrics.

BIODESIX INC strategically competes in the highly dynamic Services-Medical Laboratories marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 100.0% gross margin, indicating strong pricing power and operational efficiency.

BIODESIX INC (BDSX) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for BIODESIX INC stock analysis.

Loading BIODESIX INC comprehensive fundamental analysis and insider trading data...

Deep dive into BIODESIX INC's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if BIODESIX INC stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For BIODESIX INC: With a P/E ratio of -3.00, the market sees the stock as potentially undervalued.

P/E Ratio -3.00x
P/B Ratio 866.88x
Market Cap $987M
EPS $-0.26
Book Value/Share $0.01
Revenue/Share $0.52
FCF/Share $-0.77
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently BIODESIX INC converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For BIODESIX INC: An ROE of -234.3% indicates room for improvement in shareholder value creation.

ROE -234.3%
ROA -58.5%
ROIC -104.4%
Gross Margin 100.0%
Operating Margin -53.0%
Net Margin -66.8%
EBT Margin -160.9%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess BIODESIX INC's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For BIODESIX INC: A current ratio of 0.91 suggests potential liquidity concerns.

Current Ratio 0.91x
Quick Ratio 0.68x
D/E Ratio 1.44x
Financial Leverage 7.92x
Interest Coverage -9.4x
Working Capital $54M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal BIODESIX INC's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For BIODESIX INC: Free cash flow of $-32M indicates cash challenges that need attention.

Operating Cash Flow $-30M
Free Cash Flow $-32M
Capital Spending $-2M
FCF/Sales -100.6%
CapEx/Sales 7.4%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively BIODESIX INC uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For BIODESIX INC: An asset turnover of 0.36x suggests room for improvement in asset utilization.

Asset Turnover 0.36x
Receivables Turnover 2.9x
Fixed Assets Turnover 6.7x
Days Sales Outstanding 126 days
Payables Period 69 days
Understanding Financial Statement Data

What these metrics mean: Key figures from BIODESIX INC's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For BIODESIX INC: With annual revenue of $76M, BIODESIX INC represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $76M
R&D Expense $9M
SG&A Expense $165M
Cost of Goods Sold $48M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 44%
Cash & Short-term Investments 27%
Total Liabilities 87%
Short-term Debt 0%
Accounts Receivable 6%
Dividend & Shareholder Information
Shares Outstanding 147M
Growth Metrics (YoY)
EPS Growth -38.0%

Latest BIODESIX INC Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting BIODESIX INC (BDSX) stock price and investment outlook.

, source: Seeking Alpha

Good day, and thank you for standing by. Welcome to the Biodesix Q2 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like ...

, source: Seeking Alpha

Good day, and thank you for standing by and welcome to the Biodesix First Quarter 2023 Earnings Conference Call. At this time all participants are in a listen-only mode. After the speakers ...

, source: Nasdaq

About This EventBiodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, visits the Nasdaq MarketSite in Times Square to mark the 5 year anniversary of their IPO and Nasdaq listing.In ...

, source: Insider Monkey

Operator: Good day and thank you for standing by. Welcome to Biodesix, Inc. Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Operator: Good day ...

BIODESIX INC Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of BIODESIX INC against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ADVB Unlock Forecast - 30 Days FREE Trial $10M x 2.5x
BDSX Unlock Forecast - 30 Days FREE Trial $987M -3.0x 866.9x
BNR Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
CAI Unlock Forecast - 30 Days FREE Trial $8762M 7.6x 19.3x
CDNA Unlock Forecast - 30 Days FREE Trial $779M 15.4x 2.4x
CELC Unlock Forecast - 30 Days FREE Trial $2880M -4.5x 64.9x
CSTL Unlock Forecast - 30 Days FREE Trial $696M -2110.5x 1.5x
DGX Unlock Forecast - 30 Days FREE Trial $19860M 21.5x 2.7x
EXAS Unlock Forecast - 30 Days FREE Trial $11963M -343.6x 4.8x
FLGT Unlock Forecast - 30 Days FREE Trial $692M 516.8x 0.6x
FTRE Unlock Forecast - 30 Days FREE Trial $937M -6.8x 1.6x
GH Unlock Forecast - 30 Days FREE Trial $11552M -8.9x -23.0x
GRAL Unlock Forecast - 30 Days FREE Trial $3072M x 1.3x
LH Unlock Forecast - 30 Days FREE Trial $20918M 31.1x 2.5x
NTRA Unlock Forecast - 30 Days FREE Trial $26424M -74.2x 21.2x
PMDI Unlock Forecast - 30 Days FREE Trial $13M x 2.5x
PSNL Unlock Forecast - 30 Days FREE Trial $870M -2.3x 4.6x
RDNT Unlock Forecast - 30 Days FREE Trial $5713M 462.8x 6.1x
RENXF Unlock Forecast - 30 Days FREE Trial $13M x x
RNLXY Unlock Forecast - 30 Days FREE Trial $45M x x
SERA Unlock Forecast - 30 Days FREE Trial $166M -9.0x 1.9x
VCYT Unlock Forecast - 30 Days FREE Trial $2783M 106.0x 2.3x
XGN Unlock Forecast - 30 Days FREE Trial $259M -5.4x 12.3x

Frequently Asked Questions - BIODESIX INC Stock Forecast

How accurate are BIODESIX INC stock predictions?

Our AI model shows a 66% Spearman correlation coefficient for BDSX predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence BIODESIX INC stock price forecasts?

Our analysis considers BIODESIX INC's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is BIODESIX INC a good investment in 2025?

Based on our AI analysis, BIODESIX INC shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are BIODESIX INC forecasts updated?

BIODESIX INC stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced BIODESIX INC Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for BIODESIX INC stock.

My Portfolio

Investment Dashboard

Loading your portfolio...